• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    EMJX Enhances Gen2 Digital Asset Treasury Operating System On OpenAI's Large Language Models (LLMs) for Research and Risk Decision Support

    12/19/25 9:10:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples
    Get the next $SRXH alert in real time by email

    NORTH PALM BEACH, Fla., Dec. 19, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), which recently announced a definitive agreement to acquire EMJ Crypto Technologies ("EMJX"), today announced that EMJX is enhancing its Gen2 digital-asset treasury operating system through the integration of OpenAI's latest-generation large language models (LLMs) to support internal research workflows and risk-management decision support.

    EMJX is a digital-asset treasury operating system that applies quantitative models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. The platform is led by Eric M. Jackson and is built to manage exposure to bitcoin, Ethereum, and other select digital assets while actively addressing volatility through disciplined hedging strategies.

    The latest enhancements incorporate OpenAI's commercially available, state-of-the-art large language models into EMJX's proprietary QAM Engine and broader Gen2 Digital Asset Treasury ("Gen2 DAT") architecture, which combine quantitative models with systematic risk controls.. These models are being used to improve the synthesis of market data, macroeconomic inputs, and protocol-level information into EMJX's existing analytical and quantitative frameworks.

    This work is designed to support faster and more comprehensive research synthesis, improve retrieval-augmented analysis, and enhance how market intelligence is incorporated into portfolio construction and risk-management processes, while maintaining human oversight and established quantitative controls.

    By incorporating OpenAI-powered LLM tooling into its research and analytics stack, EMJX aims to strengthen multi-cycle strategy evaluation, dynamic volatility-management modeling, and decision support across AI-timed dollar-cost-averaging strategies, options-based hedging overlays, and multi-asset allocation within the Gen2 DAT framework.

    "We view large language models as a decision-support layer, not a replacement for disciplined risk management," said Eric Jackson, expected CEO and Chairman of EMJX upon closing of the combined company. "Using OpenAI's latest models allows us to accelerate how we ingest information, stress-test scenarios, and adapt strategy across market cycles — while keeping portfolio construction and risk controls grounded in quantitative models and human oversight."

    About EMJX

    EMJX is a Gen2 digital-asset treasury operating system designed to manage multi-asset digital holdings using quantitative models, artificial intelligence, and systematic risk controls. The platform emphasizes transparency, governance, and disciplined capital allocation across varying market environments. For more information, please visit www.emjx.ai.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "expect," "intend," "aim," "plan," "may," "could," "target," and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company's filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.

    Company Contact

    SRx Health Solutions, Inc.

    Kent Cunningham, Chief Executive Officer

    Investor Relations

    KCSA Strategic Communications

    Valter Pinto, Managing Director

    212-896-1254

    [email protected]

    Media Contact

    KCSA Strategic Communications

    Kristin Cwalinski, Senior Vice President

    [email protected]



    Primary Logo

    Get the next $SRXH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SRXH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SRXH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    EMJX Enhances Gen2 Digital Asset Treasury Operating System On OpenAI's Large Language Models (LLMs) for Research and Risk Decision Support

    NORTH PALM BEACH, Fla., Dec. 19, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), which recently announced a definitive agreement to acquire EMJ Crypto Technologies ("EMJX"), today announced that EMJX is enhancing its Gen2 digital-asset treasury operating system through the integration of OpenAI's latest-generation large language models (LLMs) to support internal research workflows and risk-management decision support. EMJX is a digital-asset treasury operating system that applies quantitative models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. The platform is led by Eric M. Jackson and is built to manag

    12/19/25 9:10:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    Platforms, Proof, and Momentum

    DENVER, Dec. 16, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions (NYSE:SRXH): A Strategic Pivot Toward Gen2 Digital Treasuries SRx Health Solutions (NYSE:SRXH) headlines the morning with a definitive agreement to acquire EMJ Crypto Technologies (EMJX), marking a transformative shift from traditional healthcare operations toward a next-generation digital-asset treasury platform. The transaction positions SRXH at the intersection of public-market governance and quantitative, AI-enabled treasury management, with closing expected in the first quarter of 2026 pending shareholder approval. Until then, shares will continue trading under the SRXH ticker, with the combined company planning to oper

    12/16/25 9:45:19 AM ET
    $AMCI
    $RILY
    $SRXH
    Home Furnishings
    Consumer Discretionary
    Investment Managers
    Finance

    SRx Health Enters into Definitive Agreement to Acquire EMJX to Establish Next-Generation Digital Asset Treasury Operating System and Platform Led by Eric M. Jackson

    NORTH PALM BEACH, Fla., Dec. 16, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced that it has entered into a definitive agreement to acquire EMJ Crypto Technologies ("EMJX"), a digital-asset treasury platform designed as a treasury operating system, applying quantitative models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. Upon completion of the transaction, Eric M. Jackson, Ph.D., Founder and Chief Executive Officer of EMJX, is expected to serve as Chief Executive Officer and Chairman of the combined company. A Gen2 Approach to Digital Asset Treasuries:EMJX is designed as a next-generation

    12/16/25 8:30:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    SEC Filings

    View All

    SEC Form 424B3 filed by SRX Health Solutions Inc.

    424B3 - SRx Health Solutions, Inc. (0001471727) (Filer)

    12/16/25 9:07:36 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRX Health Solutions Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SRx Health Solutions, Inc. (0001471727) (Filer)

    12/16/25 8:47:59 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form EFFECT filed by SRX Health Solutions Inc.

    EFFECT - SRx Health Solutions, Inc. (0001471727) (Filer)

    12/16/25 12:15:19 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director White David Allan was granted 344,975 shares, decreasing direct ownership by 97% to 6,200 units (SEC Form 4)

    4 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    10/7/25 1:46:23 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    New insider Vora Adesh Anil claimed ownership of 325,279 shares (SEC Form 3)

    3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    5/7/25 4:57:50 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    New insider Sohi Davender claimed ownership of 99,038 shares (SEC Form 3)

    3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    5/7/25 4:56:51 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    Leadership Updates

    Live Leadership Updates

    View All

    SRx Health Solutions Appoints Sammy Dorf to Board of Directors

    TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Sammy Dorf, Esq. to its Board of Directors. Sammy is a pioneering force in the modern cannabis economy and one of the industry's most accomplished dealmakers, strategists, and growth architects. Most recently serving as Executive Chairman of Flora Growth Corp. (NASDAQ:FLGC), Sammy guided the company through a transformative phase marked by innovation, disciplined expansion, and a strategic transition into a crypto treasury company. With nearly a decade of leadership at the intersection of cannabis, capital markets, and strategic development, Sammy b

    11/10/25 8:00:00 AM ET
    $FLGC
    $SRXH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee

    TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current

    10/1/25 8:00:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Obtains Initial Order under CCAA for its Canadian Subsidiary

    TAMPA, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced that its subsidiary, SRx Health Solutions (Canada), Inc.("SRx Canada") and certain of its subsidiaries obtained an Initial Order (the "Initial Order") in Canada under the federal Companies' Creditors Arrangement Act (the "CCAA" and SRx Canada's proceedings thereunder, the "CCAA Proceedings") from the Ontario Superior Court of Justice (Commercial List) (the "Court"). In connection with the Initial Order, the Court granted, among other relief: a stay of proceedings in favor of SRx Canadathe appointment of Grant Thornton Limited

    8/12/25 2:48:32 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    Financials

    Live finance-specific insights

    View All

    SRx Health Solutions Announces First Quarter 2025 Financial Results

    EPS Improved 90% Year-Over-Year to $(0.37) Adjusted EBITDA1 Loss Improved 54% Year-Over-Year to $(0.6) Million Adjusted EBITDA Margin1 Improved (9)%, a 865 Basis Point Expansion Year-Over-Year TAMPA, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions Inc. (NYSE:SRXH) (the "Company" or "SRx", previously known as "Better Choice"), a leading global health and wellness company, today announced its results for the first quarter ended March 31, 2025. "We have executed a digital first strategy in our domestic business and have implemented marketing investment shifts to grow brand awareness and discoverability," says Kent Cunningham, CEO of SRx. "We are focused on optimizing our port

    5/15/25 4:05:00 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions to Host First Quarter 2025 Financial Results Conference Call on May 15th at 4:30 p.m. ET

    TAMPA, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced it will host a conference call and webcast on Thursday, May 15, 2025, at 4:30 p.m. ET to discuss its financial results for the first quarter 2025 and provide a business update. Conference Call and Webcast Information:Event: First Quarter 2025 Financial Results Conference CallDate: Thursday, May 15, 2025Time: 4:30 p.m. Eastern TimeLive Call: 1-844-825-9789 or 1-412-317-5180Webcast:  https://srxhealth.com/events-and-presentations/ For interested individuals unable to join the conference call, the webcast replay of the call will

    5/6/25 8:45:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples